×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Genetic Counseling Market

ID: MRFR/LS/50943-HCR
200 Pages
Rahul Gotadki
October 2025

US Genetic Counseling Market Research Report: By Counseling Approach (Integrated, Independent, Discretionary Genetic Counseling), By Key Players Business Model (Core Genetic Counseling Companies, Direct-to-Consumer Genetic Testing Companies, Clinical Genetic Testing Companies), By Channel (Providers, Self-Referred Individuals), By Type of Service (Risk Assessment, Pharmacogenomics, Other Genetic Pediatric Care Counseling Services), By Application (Proactive Risk Assessment, GC For Intent-to-Treat Patients (ITT), Prenatal and Preconception Ca... read more

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Genetic Counseling Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

US Genetic Counseling Market Summary

As per MRFR analysis, the US genetic counseling market Size was estimated at 420.79 USD Million in 2024. The US genetic counseling market is projected to grow from 481.43 USD Million in 2025 to 1850.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 14.41% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The US genetic counseling market is experiencing robust growth driven by technological advancements and increasing consumer awareness.

  • The demand for genetic testing is on the rise, reflecting a growing interest in personalized healthcare solutions.
  • Telehealth services are becoming increasingly integrated into genetic counseling, enhancing accessibility for patients.
  • The largest segment in the market is prenatal genetic counseling, while the fastest-growing segment is oncology genetic counseling.
  • Key market drivers include rising awareness of genetic disorders and advancements in genetic testing technologies.

Market Size & Forecast

2024 Market Size 420.79 (USD Million)
2035 Market Size 1850.0 (USD Million)
CAGR (2025 - 2035) 14.41%

Major Players

Myriad Genetics (US), Invitae Corporation (US), Ambry Genetics (US), GeneDx (US), Fulgent Genetics (US), 23andMe (US), Color Genomics (US), Natera (US)

US Genetic Counseling Market Trends

The genetic counseling market is currently experiencing a notable evolution, driven by advancements in genomic technologies and an increasing awareness of genetic disorders. As healthcare providers and patients alike recognize the value of genetic information, the demand for counseling services is on the rise. This trend is further supported by the integration of genetic testing into routine healthcare practices, which enhances the role of genetic counselors in guiding patients through complex information. Moreover, the expansion of telehealth services has made genetic counseling more accessible, allowing individuals in remote areas to receive expert guidance without the need for travel. In addition, the growing emphasis on personalized medicine is reshaping the landscape of the genetic counseling market. Patients are increasingly seeking tailored healthcare solutions that consider their unique genetic profiles. This shift is prompting healthcare systems to invest in genetic counseling services, ensuring that patients receive appropriate support in understanding their genetic risks and making informed decisions about their health. As the market continues to evolve, it appears poised for further growth, driven by technological advancements and a heightened focus on patient-centered care.

Increased Demand for Genetic Testing

The rise in genetic testing is significantly influencing the genetic counseling market. As more individuals seek to understand their genetic predispositions, the need for professional guidance becomes essential. Genetic counselors play a crucial role in interpreting test results and providing support, which enhances patient understanding and decision-making.

Integration of Telehealth Services

Telehealth is transforming access to genetic counseling services. By utilizing digital platforms, patients can connect with genetic counselors from the comfort of their homes. This trend is particularly beneficial for those in underserved areas, as it expands the reach of counseling services and facilitates timely consultations.

Focus on Personalized Medicine

The shift towards personalized medicine is reshaping the genetic counseling market. Patients are increasingly interested in tailored healthcare solutions that consider their genetic makeup. This trend encourages healthcare providers to enhance their genetic counseling services, ensuring that patients receive customized support based on their unique genetic profiles.

US Genetic Counseling Market Drivers

Rising Awareness of Genetic Disorders

The growing awareness of genetic disorders among the general population is a key driver for the genetic counseling market. As individuals become more informed about hereditary conditions, the demand for genetic counseling services increases. Educational campaigns and advocacy groups play a significant role in disseminating information about genetic risks and testing options. This heightened awareness is reflected in the increasing number of individuals seeking genetic counseling, with estimates suggesting that the market could grow at a CAGR of 10% over the next five years. The genetic counseling market is thus positioned to benefit from this trend, as more people recognize the importance of understanding their genetic health.

Increased Focus on Preventive Healthcare

The shift towards preventive healthcare is influencing the genetic counseling market positively. As healthcare systems emphasize early detection and prevention of diseases, genetic counseling becomes an integral part of patient care. Individuals are increasingly seeking genetic counseling to understand their risk factors and make informed lifestyle choices. This trend is supported by healthcare providers who recognize the value of genetic insights in preventing diseases. The genetic counseling market is likely to experience growth as more healthcare systems integrate genetic counseling into their preventive care strategies, potentially increasing the market size by 15% over the next few years.

Legislative Support for Genetic Services

Legislative measures aimed at supporting genetic services are emerging as a significant driver for the genetic counseling market. Policies that promote insurance coverage for genetic testing and counseling services enhance accessibility for patients. For instance, the Genetic Information Nondiscrimination Act (GINA) protects individuals from discrimination based on genetic information, encouraging more people to seek genetic counseling. This supportive legal framework is crucial for the growth of the genetic counseling market, as it fosters an environment where individuals feel secure in pursuing genetic testing without fear of repercussions. The market is expected to expand as more states adopt similar protective measures.

Growing Demand for Family Planning Services

The rising demand for family planning services is a notable driver for the genetic counseling market. Couples planning to start families are increasingly interested in understanding their genetic backgrounds to assess potential risks for inherited conditions. This trend is particularly evident among individuals with a family history of genetic disorders. Genetic counseling provides essential information that aids in making informed reproductive choices. The genetic counseling market is expected to benefit from this growing demand, as more couples seek professional guidance to navigate their genetic health, potentially leading to a market expansion of 12% annually.

Advancements in Genetic Testing Technologies

Technological advancements in genetic testing are transforming the landscape of the genetic counseling market. Innovations such as next-generation sequencing (NGS) and CRISPR technology have made genetic testing more accessible and affordable. These advancements enable more comprehensive testing for a variety of genetic conditions, which in turn drives the demand for genetic counseling services. As testing becomes more sophisticated, the need for professional guidance to interpret results and make informed decisions increases. The genetic counseling market is likely to see substantial growth as these technologies continue to evolve, potentially reaching a market value of $1 billion by 2027.

Market Segment Insights

By Counseling Approach: Integrated (Largest) vs. Discretionary Genetic Counseling (Fastest-Growing)

In the US genetic counseling market, the Integrated approach holds the largest share among counseling approaches, reflecting a robust infrastructure and established practices within healthcare systems. This segment benefits strongly from the collaborative networks between healthcare providers and genetic counselors, ensuring comprehensive patient care and support throughout the genetic testing journey. On the other hand, Discretionary Genetic Counseling is emerging as the fastest-growing segment, driven primarily by increasing consumer demand for personalized health information and services that cater to specific patient needs. The rise in awareness and the reduction of stigma surrounding genetic testing are also significant factors propelling the growth of this segment, allowing more individuals to seek genetic guidance tailored to their unique circumstances.

Integrated (Dominant) vs. Discretionary Genetic Counseling (Emerging)

The Integrated approach is characterized by its deep integration within medical settings, where genetic counseling services are often part of broader healthcare services. This model provides a seamless experience for patients, allowing for enhanced collaboration among medical professionals. In contrast, Discretionary Genetic Counseling represents a more flexible and patient-driven model, appealing to individuals seeking targeted advice without necessarily routing through traditional healthcare systems. This emerging model leverages advancements in digital health platforms, allowing consumers to access genetic counseling services based on their specific preferences and circumstances, and is rapidly gaining traction among younger populations seeking autonomy in their healthcare decisions.

By Key Players Business Model: Core Genetic Counseling Companies (Largest) vs. Direct-to-Consumer Genetic Testing Companies (Fastest-Growing)

The market shares across the key players business models in the genetic counseling landscape reflect a diverse distribution, with core genetic counseling companies commanding the largest share. These companies focus on providing professional counseling services alongside genetic testing, ensuring a holistic approach to patient care. Meanwhile, direct-to-consumer genetic testing companies are becoming increasingly prominent, catering to a growing consumer preference for accessible, at-home testing solutions. Growth trends indicate a robust expansion within these models, driven by advancements in technology and heightened awareness of genetic health. Core genetic counseling companies benefit from established networks and reputation, while direct-to-consumer testing firms capitalize on the convenience and immediacy of their offerings. Clinical genetic testing companies, while integral, are experiencing a moderate growth trajectory compared to the rapid ascent of direct testing models, highlighting a shift towards consumer engagement in genetic health management.

Core Genetic Counseling Companies (Dominant) vs. Direct-to-Consumer Genetic Testing Companies (Emerging)

Core genetic counseling companies are characterized by their comprehensive approach to genetic health, integrating counseling services with genetic testing. These players leverage professional expertise to provide nuanced insights that help patients understand their genetic risks and options. Their dominant position stems from the trust established within clinical settings and their ability to cater to complex genetic inquiries. In contrast, direct-to-consumer genetic testing companies represent an emerging trend, offering simplified access to genetic information without the need for intermediary counseling. They appeal to a tech-savvy demographic seeking quick results and personalized insights, positioning themselves as companions in the journey of health empowerment. This dynamic between dominance and emergence illustrates the evolving landscape of genetic services.

By Channel: Providers (Largest) vs. Self-Referred Individuals (Fastest-Growing)

In the US genetic counseling market, providers remain the dominant force, capturing a significant portion of the market share due to their established infrastructure and trust within the healthcare community. This segment includes genetic counselors working in hospitals, clinics, and private practices, who actively engage with patients to provide tailored genetic counseling services. Self-referred individuals, while smaller in share, represent a dynamic shift within the market, as more patients proactively seek out genetic testing services without a direct referral from healthcare providers. Looking ahead, growth trends indicate a rise in self-referred individuals, driven by increased awareness and accessibility of genetic testing. Advances in technology and online platforms have made it easier for individuals to pursue genetic counseling independently. Additionally, social media and educational resources are empowering more people to take charge of their health, creating a burgeoning market for self-referred genetic counseling services, leading to their identification as the fastest-growing segment in this area.

Providers: Dominant vs. Self-Referred Individuals: Emerging

The providers segment in the US genetic counseling market embodies a well-established and trusted system within healthcare. Composed of trained genetic counselors, this segment continues to hold a strong position, driven by relationships with medical institutions and the emphasis on professional qualifications. Providers not only offer in-depth genetic insights but also ensure adherence to ethical standards, fostering patient trust. On the other hand, self-referred individuals are characterized by a growing trend of patients actively seeking genetic counseling services without physician referrals. This emerging group showcases an increasing role of consumer autonomy in healthcare, drawing interest from industry stakeholders who perceive potential in developing tailored services and marketing strategies to meet the needs of this dynamic segment.

By Type of Service: Risk Assessment (Largest) vs. Pharmacogenomics (Fastest-Growing)

In the US genetic counseling market, the distribution of services reveals that Risk Assessment holds the largest share, catering extensively to patients seeking insights into hereditary conditions. This service benefits from a well-established framework and increasing awareness among the population. In contrast, Pharmacogenomics, although a smaller segment, is rapidly expanding as personalized medicine gains traction, highlighting the growing consumer interest in tailored treatment options. The growth trends within the US genetic counseling market are driven by technological advancements and an increasing focus on preventive healthcare. As healthcare providers improve their genetic screening capabilities, the demand for Risk Assessment and Pharmacogenomics services is expected to rise significantly. Furthermore, as patients become more educated about genetic testing, the willingness to invest in these services is set to increase, amplifying the growth potential in the coming years.

Risk Assessment: Dominant vs. Pharmacogenomics: Emerging

Risk Assessment services dominate the US genetic counseling market due to their foundational role in identifying genetic predispositions among individuals and families. This service is characterized by its comprehensive approach, offering detailed evaluations to help manage patient care effectively. Conversely, Pharmacogenomics is emerging as a significant player, focusing on how genes influence drug response, making it increasingly relevant in personalized medicine. The demand for this service is propelled by the rise in chronic diseases and the need for customized therapies. As healthcare continues to evolve, both segments represent crucial components, with Risk Assessment leading the market and Pharmacogenomics poised to capture a growing share.

By Application: Prenatal and Preconception Care (Largest) vs. Proactive Risk Assessment (Fastest-Growing)

In the US genetic counseling market, Prenatal and Preconception Care holds the largest share, reflecting a significant focus on preparing prospective parents for healthy pregnancies. This segment appeals to a wide audience, including expectant mothers and couples planning families, thus contributing to its dominance. Conversely, Proactive Risk Assessment is emerging rapidly, showcasing a growing awareness of genetic testing and personalized healthcare tailored toward early detection of potential health risks. The growth trends in this segment are driven by advances in genetic testing technologies and increased public awareness about hereditary conditions. There is a notable rise in demand for proactive approaches to health management, leading to a surge in the number of individuals seeking genetic counseling services. Additionally, as healthcare providers emphasize preventive care, the Proactive Risk Assessment segment is likely to witness sustained growth moving forward.

Prenatal and Preconception Care (Dominant) vs. Proactive Risk Assessment (Emerging)

Prenatal and Preconception Care is characterized by its focus on guiding individuals through pregnancy-related genetic health issues, ensuring informed decision-making for potential parents. This segment's extensive reach is attributed to its ability to address various genetic conditions, offering tailored advice and support. On the other hand, Proactive Risk Assessment is gaining traction as an emerging segment that emphasizes early identification of genetic predispositions to diseases. It caters to an increasing number of health-conscious consumers looking to engage in preventive measures. Both segments represent crucial components of the US genetic counseling market, with Prenatal and Preconception Care remaining dominant while Proactive Risk Assessment is carving out its space as an essential service.

By Target Population Segment: General Population (Largest) vs. Patient Population (Fastest-Growing)

The US genetic counseling market displays a significant market share distribution between the General Population and Patient Population segments. The General Population constitutes the largest portion of the market, making genetic counseling widely accessible and appealing to those without specific medical histories. In contrast, the Patient Population segment, representing individuals with existing health concerns, has been increasingly recognized and prioritized, leading to its rapid growth in recent years. Growth trends indicate that the Patient Population is expanding faster due to rising awareness and demand for personalized healthcare solutions. Factors driving this growth include advancements in genetic testing technology, increasing prevalence of genetic disorders, and a growing emphasis on preventive healthcare measures. As consumers and healthcare providers recognize the importance of genetic counseling, the Patient Population is set to become a vital force in shaping the future landscape of this market.

General Population (Dominant) vs. Patient Population (Emerging)

The General Population segment in the US genetic counseling market is characterized by its broad accessibility and appeal to individuals seeking information and guidance regarding their genetic risks. This segment includes healthy individuals who may be proactive about their health and wellness, representing a substantial portion of the market. Conversely, the Patient Population is emerging rapidly, driven by individuals with diagnosed conditions or concerns. This segment is distinguished by its targeted nature, focusing on patients who require specific genetic insights to manage their health more effectively. Both segments play crucial roles, but the dynamics of their growth suggest a shift towards more personalized and patient-centered approaches, reshaping the overall landscape of genetic counseling.

By Level of Service: Pre-counseling Support (Largest) vs. Post Counseling Support (Fastest-Growing)

In the US genetic counseling market, Pre-counseling Support holds the largest share, serving as a crucial first step in the genetic counseling process. This segment is dedicated to providing prospective patients with essential information and resources before they engage in counseling sessions. By contrast, Post Counseling Support is emerging as the fastest-growing segment, reflecting an increasing recognition of the importance of continuous care and support after initial consultations. As patients increasingly seek follow-up services to better manage their genetic insights, this area is experiencing rapid expansion. Growth trends in this segment are primarily driven by rising awareness of genetic testing and its implications for health. The demand for comprehensive services that include both pre and post-counseling support is on the rise, influenced by the broader acceptance of genetic counseling among diverse populations. Factors including technological advancements and increased access to healthcare services contribute to the growth of post counseling support, making it a vital and expanding component of the US genetic counseling market.

Pre-counseling Support: Dominant vs. Post Counseling Support: Emerging

Pre-counseling Support plays a dominant role in the US genetic counseling market by offering vital educational resources and personalized guidance to individuals considering genetic testing. This segment helps set the foundation for informed decision-making, ensuring patients feel prepared and supported. On the other hand, Post Counseling Support is an emerging segment that addresses the follow-up needs of patients after they have undergone genetic counseling. It focuses on providing resources and ongoing communication, which are essential for effective utilization of genetic results. Patients increasingly value this type of support, leading to rapid growth in its market presence as healthcare providers recognize the importance of sustained engagement in enhancing patient outcomes.

Get more detailed insights about US Genetic Counseling Market
Request Free Sample

Key Players and Competitive Insights

The genetic counseling market is currently characterized by a dynamic competitive landscape, driven by advancements in technology, increasing consumer awareness, and a growing emphasis on personalized medicine. Key players such as Myriad Genetics (US), Invitae Corporation (US), and 23andMe (US) are strategically positioning themselves through innovation and partnerships. Myriad Genetics (US) focuses on expanding its genetic testing portfolio, while Invitae Corporation (US) emphasizes accessibility and affordability in genetic testing services. Meanwhile, 23andMe (US) leverages its direct-to-consumer model to enhance engagement and data collection, collectively shaping a competitive environment that prioritizes consumer-centric solutions and technological integration.

In terms of business tactics, companies are increasingly localizing their operations and optimizing supply chains to enhance efficiency and responsiveness. The market appears moderately fragmented, with several players vying for market share, yet the influence of major companies is substantial. This competitive structure fosters an environment where innovation and strategic partnerships are essential for maintaining a competitive edge.

In October 2025, Myriad Genetics (US) announced a collaboration with a leading healthcare provider to integrate genetic counseling services into routine patient care. This strategic move is likely to enhance patient access to genetic counseling, thereby increasing the adoption of genetic testing and personalized treatment plans. Such partnerships may also facilitate the sharing of resources and expertise, ultimately benefiting patient outcomes.

In September 2025, Invitae Corporation (US) launched a new telehealth platform aimed at streamlining the genetic counseling process. This initiative is significant as it addresses the growing demand for remote healthcare services, particularly in underserved areas. By enhancing accessibility, Invitae Corporation (US) positions itself as a leader in the digital transformation of genetic counseling, potentially increasing its market share.

In August 2025, 23andMe (US) expanded its genetic testing offerings to include additional health reports, focusing on chronic disease risk assessment. This expansion reflects a strategic effort to diversify its product line and cater to a broader audience. By providing more comprehensive health insights, 23andMe (US) may strengthen its competitive position and enhance customer loyalty.

As of November 2025, current trends in the genetic counseling market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in service delivery. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, underscoring the importance of adaptability in a rapidly changing market.

Key Companies in the US Genetic Counseling Market market include

Industry Developments

Recent developments in the US Genetic Counseling Market include the growing integration of genetic testing into routine healthcare, particularly due to advancements from companies like Invitae and Ambry Genetics, which have expanded their testing portfolios. In September 2023, Natera announced a strategic partnership with multiple healthcare providers to enhance access to genetic counseling services. Additionally, Myriad Genetics has made significant strides in expanding telehealth services for remote genetic counseling, providing increased accessibility to patients nationwide.

Mergers and acquisitions have shaped the landscape, with Genoox acquiring key genetic data platforms in June 2023 to bolster its analytics capabilities, and Fulgent Genetics announcing its acquisition of a notable genetic testing firm in July 2023 to expand its service offerings. The market is witnessing growth in valuation, driven by increasing data-driven personalized medicine demands and advancements in genomic technologies. The financial backing from private equity investments continues to fuel innovation in this sector, indicating a robust trend toward enhanced genetic services and counseling availability.

Major happenings over the last few years, such as the rise of 23andMe's direct-to-consumer models and Color Genomics' expansion in hereditary health services (notable developments in October 2021), have also played a pivotal role in shaping the market dynamics.

Future Outlook

US Genetic Counseling Market Future Outlook

The Genetic Counseling Market is projected to grow at a 14.41% CAGR from 2024 to 2035, driven by advancements in genomics, increased awareness, and rising demand for personalized healthcare.

New opportunities lie in:

  • Development of telehealth platforms for remote genetic counseling services.
  • Integration of AI-driven tools for enhanced risk assessment and patient management.
  • Expansion of genetic testing services in underserved regions to capture new patient demographics.

By 2035, the genetic counseling market is expected to be robust, reflecting significant growth and innovation.

Market Segmentation

US Genetic Counseling Market Channel Outlook

  • Providers
  • Self-Referred Individuals

US Genetic Counseling Market Application Outlook

  • Proactive Risk Assessment
  • GC For Intent-to-Treat Patients (ITT)
  • Prenatal and Preconception Care
  • Others

US Genetic Counseling Market Type of Service Outlook

  • Risk Assessment
  • Pharmacogenomics
  • Other Genetic Pediatric Care Counseling Services

US Genetic Counseling Market Level of Service Outlook

  • Pre-counseling Support
  • Post Counseling Support

US Genetic Counseling Market Counseling Approach Outlook

  • Integrated
  • Independent
  • Discretionary Genetic Counseling

US Genetic Counseling Market Target Population Segment Outlook

  • General Population
  • Patient Population

US Genetic Counseling Market Key Players Business Model Outlook

  • Core Genetic Counseling Companies
  • Direct-to-Consumer Genetic Testing Companies
  • Clinical Genetic Testing Companies

Report Scope

MARKET SIZE 2024 420.79(USD Million)
MARKET SIZE 2025 481.43(USD Million)
MARKET SIZE 2035 1850.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 14.41% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Myriad Genetics (US), Invitae Corporation (US), Ambry Genetics (US), GeneDx (US), Fulgent Genetics (US), 23andMe (US), Color Genomics (US), Natera (US)
Segments Covered Counseling Approach, Key Players Business Model, Channel, Type of Service, Application, Target Population Segment, Level of Service
Key Market Opportunities Integration of artificial intelligence in genetic counseling enhances personalized patient care and decision-making.
Key Market Dynamics Growing demand for personalized medicine drives expansion and innovation in the genetic counseling market.
Countries Covered US

Leave a Comment

FAQs

What was the expected market size of the US Genetic Counseling Market in 2024?

The US Genetic Counseling Market was expected to be valued at 421.4 million USD in 2024.

What will be the market value of the US Genetic Counseling Market by 2035?

By 2035, the US Genetic Counseling Market is projected to reach a value of 1,036.0 million USD.

What is the compound annual growth rate (CAGR) for the US Genetic Counseling Market from 2025 to 2035?

The CAGR for the US Genetic Counseling Market is expected to be 8.521% from 2025 to 2035.

Which counseling approach is projected to have the largest market value in 2035?

The Integrated counseling approach is projected to have the largest market value of 430.0 million USD in 2035.

How much was the Independent counseling approach valued at in 2024?

The Independent counseling approach was valued at 150.0 million USD in 2024.

What is the market size for Discretionary Genetic Counseling in 2035?

Discretionary Genetic Counseling is expected to reach a market size of 246.0 million USD by 2035.

Who are some of the key players in the US Genetic Counseling Market?

Key players in the US Genetic Counseling Market include Karius, Ambry Genetics, Genoox, and Natera, among others.

What is a significant growth opportunity within the US Genetic Counseling Market?

The rising demand for personalized healthcare solutions presents a significant growth opportunity in the US Genetic Counseling Market.

Is there any expected impact on the US Genetic Counseling Market due to global conflicts?

Current global conflicts may influence the supply chain and operational dynamics of the US Genetic Counseling Market.

Which segment is expected to experience substantial growth from 2025 to 2035?

The Integrated counseling approach is expected to experience substantial growth during the forecast period from 2025 to 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓